The Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades; Kimberly Mauer, M.D., says, "The more options we have, the better we’re able to treat each and every patient.”

OHSU is a collaborative partner in a new research project showing early promise in the treatment of Parkinson's disease in fruit flies.

Media outlets report on a new non-opioid pain reliever approved by the FDA — the first to be approved in more than two decades. Kimberly Mauer M.D., says, “The more options we have, the better we’re able to treat each and every patient … .[Insurance coverage] might limit some patients getting it, so we just have to kind of see, and it’s hard to tell until it kind of gets out on the market.”

In a story about a new $4 million Department of Defense-funded research award related to examining the brain’s ability to clear metabolic waste through the glymphatic system, KGW-TV interviews Jonathan Elliott, Ph.D., and Miranda Lim, M.D., Ph.D., who says, “If we can figure out ways to improve sleep and improve the glymphatic system, that’s really the key to overall health and being able to be our best selves.”

OHSU researchers make new discoveries about amniotic fluid, including its ability to improving the blood thickening and clotting throughout pregnancy and delivery. Brian Scottoline, M.D., Ph.D., says, “Babies born prematurely miss out on critical weeks developing within amniotic fluid. But if we have a better understanding of amniotic fluid, how it develops and what properties are valuable for what functions, that opens up many new possibilities for creating new therapies.”

Healio discusses how inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients. Kevin Winthrop M.D., says, “A lot of those places have institutional memory and have good people who have been working there for years, so it is difficult to say what kind of policy changes may occur … . Whatever happens with those wild cards, keep doing your job and keep working hard. Science is science.”

Media outlets report on a new non-opioid pain reliever approved by the FDA — the first to be approved in more than two decades. Kimberly Mauer M.D., says, “The more options we have, the better we’re able to treat each and every patient … .[Insurance coverage] might limit some patients getting it, so we just have to kind of see, and it’s hard to tell until it kind of gets out on the market.”

Huff Post covers the effectiveness of sauna blankets, a product promising improvements in blood flow, stress, chronic pain and more. Sean Robinson M.D., says, “Most people would recommend about 150 degrees Fahrenheit for 20-ish minutes. ... That’s where you get most of your health benefits. … Because of the temperature limitations [with sauna blankets], you’re probably not getting the full benefits of sauna that is well established in the literature.”

OHSU researchers make new discoveries about amniotic fluid, including its ability to improving the blood thickening and clotting throughout pregnancy and delivery. Brian Scottoline, M.D., Ph.D., says, “Babies born prematurely miss out on critical weeks developing within amniotic fluid. But if we have a better understanding of amniotic fluid, how it develops and what properties are valuable for what functions, that opens up many new possibilities for creating new therapies.”

OHSU researchers make new discoveries about amniotic fluid, including its ability to improving the blood thickening and clotting throughout pregnancy and delivery. Brian Scottoline, M.D., Ph.D., says, “Babies born prematurely miss out on critical weeks developing within amniotic fluid. But if we have a better understanding of amniotic fluid, how it develops and what properties are valuable for what functions, that opens up many new possibilities for creating new therapies.”